Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department
Stopped early · Not applicable · Has a placebo group
Conditions studied: Abscess
In brief
The purpose of this study is to determine if there is a difference between an antibiotic, trimethoprim-sulfamethoxazole versus placebo in healing outcomes of soft tissue abscesses following incision and drainage.
Key facts
- Study ID
- NCT00867789
- Run by
- Children's Mercy Hospital Kansas City
- People needed
- 140
- Starts
- 2009-03-01
- Expected to finish
- 2012-10-01
- Last updated by the study team
- 2021-01-26
Who can join
Age: 0 and older, up to 17. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 3 months to 17 years
- Single, localized soft tissue abscesses requiring incision and drainage with purulent material obtained
- Diameter of the abscess less than 5cm as measured by the treating physician
You may not qualify if…
- Signs of systemic illness or ill-appearing, as determined by the treating physician
- Admission to the hospital following treatment in the Emergency Department
- Known sulfa allergy
- Immunocompromised patients
- Soft tissue abscesses involving the perineum (labia, scrotum, penis, perirectal)
- Previous antibiotic use (for any reason) in the past seven days
- Non-English speaking patients and families
Where it is running
- Children's Mercy Hospitals and Clinics — Kansas City, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.